missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ST3 beta-Gal alpha-2,3-Sialyltransferase 2/ST3GAL2 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody has been used in 1 publication
Brand: Novus Biologicals NBP1-87044
This item is not returnable.
View return policy
Description
ST3 beta-Gal alpha-2,3-Sialyltransferase 2/ST3GAL2 Polyclonal specifically detects ST3 beta-Gal alpha-2,3-Sialyltransferase 2/ST3GAL2 in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Specifications
| ST3 beta-Gal alpha-2,3-Sialyltransferase 2/ST3GAL2 | |
| Polyclonal | |
| Immunohistochemistry, Immunohistochemistry-Paraffin 1:50 - 1:200 | |
| Alpha 2,3-ST 2, Beta-galactoside alpha-2,3-sialyltransferase 2, beta-galactoside alpha-2,3-sialytransferase, CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2, EC 2.4.99.4, EC 2.4.99.7, Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase, Gal-NAc6S, Sialyltransferase 4B, sialyltransferase 4B (beta-galactosidase alpha-2,3-sialytransferase), SIAT4B, SIAT4-B, ST3 beta-galactoside alpha-2,3-sialyltransferase 2, ST3GalA.2ST3Gal II, ST3GALII | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| 6483 | |
| Human | |
| IgG |
| Immunohistochemistry, Immunohistochemistry (Paraffin) | |
| Unconjugated | |
| PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
| ST3GAL2 | |
| This antibody was developed against Recombinant Protein corresponding to amino acids:ATLPYLDSGALDGTHRVKLVPGYAGLQRLSKERLSGKSCACRRCMGDAGASDWFDSHFDGNISPVWTRENMDLPPDVQRWWMMLQPQFKSHNTNEVLEKLFQIVPGENPYRFRDPHQCRRCAVVGNSGNLRGSGYGQDVD | |
| 0.1 mL | |
| Primary | |
| Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction